Jenny Ho

872 total citations
25 papers, 584 citations indexed

About

Jenny Ho is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Jenny Ho has authored 25 papers receiving a total of 584 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 11 papers in Oncology and 9 papers in Immunology. Recurrent topics in Jenny Ho's work include Acute Myeloid Leukemia Research (9 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers) and Phagocytosis and Immune Regulation (5 papers). Jenny Ho is often cited by papers focused on Acute Myeloid Leukemia Research (9 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers) and Phagocytosis and Immune Regulation (5 papers). Jenny Ho collaborates with scholars based in Canada, United Kingdom and United States. Jenny Ho's co-authors include Dwayne L. Barber, Jean Wang, Bryan K. Beattie, Rosa Viner, Manuel Mayr, Marshall Bern, Xiaoke Yin, Mark D. Minden, Liqing Jin and John E. Dick and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and Blood.

In The Last Decade

Jenny Ho

23 papers receiving 578 citations

Peers

Jenny Ho
Jennifer Fraszczak Canada
Maja Ludvigsen Denmark
Matthew J. Saabye United States
Marina Lanciotti Italy
Olga Sala‐Torra United States
Hannah J. Lomax-Browne United Kingdom
Bangzheng Chen United States
Nicolas Chatain Germany
Grégory Ehx Belgium
Nandini Mondal United States
Jennifer Fraszczak Canada
Jenny Ho
Citations per year, relative to Jenny Ho Jenny Ho (= 1×) peers Jennifer Fraszczak

Countries citing papers authored by Jenny Ho

Since Specialization
Citations

This map shows the geographic impact of Jenny Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jenny Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jenny Ho more than expected).

Fields of papers citing papers by Jenny Ho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jenny Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jenny Ho. The network helps show where Jenny Ho may publish in the future.

Co-authorship network of co-authors of Jenny Ho

This figure shows the co-authorship network connecting the top 25 collaborators of Jenny Ho. A scholar is included among the top collaborators of Jenny Ho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jenny Ho. Jenny Ho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chin‐Yee, Benjamin, et al.. (2025). Diagnosis, management, and outcomes of drug-induced erythrocytosis: a systematic review. Blood Advances. 9(9). 2108–2118. 4 indexed citations
2.
Knauer, Michael J., Alejandro Lazo‐Langner, Joy Mangel, et al.. (2024). Serologic Response to Vaccine for COVID-19 in Patients with Hematologic Malignancy: A Prospective Cohort Study. Clinical Lymphoma Myeloma & Leukemia. 24(5). 305–315. 1 indexed citations
3.
Chin‐Yee, Benjamin, Jenny Ho, Alejandro Lazo‐Langner, et al.. (2024). An Approach to the Investigation of Thrombocytosis: Differentiating between Essential Thrombocythemia and Secondary Thrombocytosis. Advances in Hematology. 2024(1). 3056216–3056216. 1 indexed citations
4.
5.
6.
7.
Chin‐Yee, Benjamin, Ian Cheong, Cyrus C. Hsia, et al.. (2022). A Rational Approach to JAK2 Mutation Testing in Patients with Elevated Hemoglobin: Results from the JAK2 Prediction Cohort (JAKPOT) Study. Journal of General Internal Medicine. 38(8). 1828–1833. 6 indexed citations
8.
Chin‐Yee, Benjamin, Ian Cheong, Cyrus C. Hsia, et al.. (2021). A Prediction Rule to Guide JAK2 Testing in Patients with Suspected Polycythemia Vera. Blood. 138(Supplement 1). 4635–4635.
9.
Louzada, Martha, Arleigh McCurdy, Sudeep Shivakumar, et al.. (2021). Rivaroxaban for Improvement in Thromboembolism Outcomes in Patients with Multiple Myeloma on Lenalidomide-Based Therapy: The Rithmm Feasibility Pilot Trial. Blood. 138(Supplement 1). 3232–3232. 2 indexed citations
10.
Ho, Jenny, Stephanie M. Dobson, Véronique Voisin, et al.. (2020). CD200 expression marks leukemia stem cells in human AML. Blood Advances. 4(21). 5402–5413. 37 indexed citations
11.
Ho, Jenny, Stephanie M. Dobson, Jessica McLeod, et al.. (2016). CD200 Is a Marker of LSC Activity in Acute Myeloid Leukemia. Blood. 128(22). 1705–1705. 2 indexed citations
12.
Muccilli, Vera, Rosaria Saletti, Vincenzo Cunsolo, et al.. (2014). Protein profile of exhaled breath condensate determined by high resolution mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 105. 134–149. 34 indexed citations
13.
Murray, Euan, Lenka Hernychová, Michaela Ščigelová, et al.. (2014). Quantitative Proteomic Profiling of Pleomorphic Human Sarcoma Identifies CLIC1 as a Dominant Pro-Oncogenic Receptor Expressed in Diverse Sarcoma Types. Journal of Proteome Research. 13(5). 2543–2559. 8 indexed citations
14.
Ho, Jenny, Jayne S. Danska, & Jean Wang. (2013). Targeting SIRPα in cancer. OncoImmunology. 2(2). e23081–e23081. 4 indexed citations
15.
Yin, Xiaoke, et al.. (2013). Glycoproteomic Analysis of the Secretome of Human Endothelial Cells. Molecular & Cellular Proteomics. 12(4). 956–978. 86 indexed citations
16.
Uger, Robert A., Xinli Pang, Mark Wong, et al.. (2013). Blockade Of CD47 Using SIRPαFc: Role Of The Fc Region In Anti-Leukemic Activity and Tolerability. Blood. 122(21). 3935–3935. 3 indexed citations
17.
Theocharides, Alexandre, Liqing Jin, Jenny Ho, et al.. (2012). Disruption of SIRPα signaling in macrophages eliminates human acute myeloid leukemia stem cells in xenografts. The Journal of Experimental Medicine. 209(10). 1883–1899. 113 indexed citations
18.
Ho, Jenny, Jamil Dierov, Bryan K. Beattie, et al.. (2002). TEL-JAK2 constitutively activates the extracellular signal-regulated kinase (ERK), stress-activated protein/Jun kinase (SAPK/JNK), and p38 signaling pathways.. Blood. 100(4). 1438–48. 32 indexed citations
19.
Rottapel, Robert, Subburaj Ilangumaran, Chris Neale, et al.. (2002). The tumor suppressor activity of SOCS-1. Oncogene. 21(28). 4351–4362. 111 indexed citations
20.
Ho, Jenny, et al.. (2001). TEL-JAK2 Mediates Constitutive Activation of the Phosphatidylinositol 3′-Kinase/Protein Kinase B Signaling Pathway. Journal of Biological Chemistry. 276(35). 32704–32713. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jennifer Fraszczak Breakdown of academic impact, for papers by Maja Ludvigsen Breakdown of academic impact, for papers by Matthew J. Saabye Breakdown of academic impact, for papers by Marina Lanciotti Breakdown of academic impact, for papers by Olga Sala‐Torra Breakdown of academic impact, for papers by Hannah J. Lomax-Browne Breakdown of academic impact, for papers by Bangzheng Chen Breakdown of academic impact, for papers by Nicolas Chatain Breakdown of academic impact, for papers by Grégory Ehx Breakdown of academic impact, for papers by Nandini Mondal
Rankless by CCL
2026